Potential lncRNA SNHG16/hsa-miR-30b-5p/LARP1 and lncRNA LINC00707/hsa-miR-30b-5p/LARP1 regulatory networks may offer new therapeutic targets, aiding in the development of personalized HNSCC treatments. This evidence concerns the gene LARP1 and head and neck squamous cell carcinoma.